Dr. David C. Whitcomb discusses precision medicine diagnosis and management.
Educational Objectives:
Upon completion of this activity, participants should be able to:
- Explain the different goals of traditional Western medicine and precision medicine
- Recognize the need for disease models in precision medicine
- Describe targeted treatment of a pancreatic disease that includes genetic and functional testing
Disclosures:
Dr. David C. Whitcomb has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Grant/Research Support: NIH, DOD, Shire
- Consultant: AbbVie, Ariel precision Medicine, Regeneron
- Stockholder: Ariel Precision Medicine
- Other: ACG, Editor-in-Chief: Clinical and Translational Gastroenterology, UpToDate, Section Editor - Pancreas, Board Member at National Pancreas Foundation
Accreditation Statement:
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (.05) continuing education units (CEU) which are equivalent to .50 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 5/16/2019 | Last Modified On: 5/16/2019 | Expires: 5/18/2020
